Media Centre
© Enthera. All rights reserved
Enthera Srl, Via Gioberti, 8, 20123 Milano, Italy
T: +39 02 49533580
E: info@entherapharmaceuticals.com
Enthera Srl, Via Gioberti, 8, 20123 Milano, Italy
T: +39 02 49533580
E: info@entherapharmaceuticals.com
Website by Instinctif Partners
Enthera Pharmaceuticals nomina Aled Williams come amministratore delegato
/in Press ReleasesMilano, 4 maggio 2022 – Enthera Pharmaceuticals (“Enthera”), azienda biotecnologica che sviluppa farmaci biologici “first in class” per alcune malattie autoimmuni nelle quali è coinvolto un nuovo meccanismo di apoptosi, annuncia oggi la nomina di Aled Williams a amministratore delegato e membro del suo Consiglio di Amministrazione. Aled ha oltre venticinque anni di esperienza in posizioni […]
Enthera Pharmaceuticals Appoints Aled Williams as Chief Executive Officer
/in Press ReleasesMilan, Italy, 4 May 2022 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, today announces the appointment of Aled Williams as Chief Executive Officer and member of its Board of Directors. Aled has over twenty-five years of experience as a senior […]
Enthera Pharmaceuticals, Boston Children’s Hospital of the Harvard Medical School and the University of Milan reveal use of novel pathway to restore pancreatic cell function in diabetes in Nature Communications
/in Press ReleasesNew publication titled ‘The IGFBP3/TMEM219 pathway regulates β-cell homeostasis’ published in leading peer-review journal, Nature Communications The research confirms that the recently discovered ‘IGFBP3/TMEM219’ apoptosis pathway plays a key role in beta cell homeostasis, and has the potential to be utilized as a new therapeutic approach for type 1 diabetes Enthera aims to leverage the IGFBP3/TMEM219 pathway to […]